Literature DB >> 17376905

Sequential autoprocessing of Marek's disease herpesvirus protease differs from that of other herpesviruses.

S Laurent1, C Blondeau, M Belghazi, S Remy, E Esnault, P Rasschaert, D Rasschaert.   

Abstract

Herpesviruses encode a unique serine protease essential for viral capsid maturation. This protease undergoes autoprocessing at two sites, R and M, at the consensus sequence (V, L, I)(P3)-X(P2)-A(P1)/S(P1') (where X is a polar amino acid). We observed complete autoprocessing at the R and M sites of Marek's disease virus (MDV) protease following production of the polyprotein in Escherichia coli. Site-directed mutagenesis confirmed the predicted sequence of the R and M sites, with the M site sequence being nonconsensual: M(P3)-N(P2)-A(P1)/S(P1'). Mutagenesis and expression kinetics studies suggested that the atypical MDV M site was cleaved exclusively by the processed short protease, a feature making MDV unique among herpesviruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376905      PMCID: PMC1900316          DOI: 10.1128/JVI.02679-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Recombinant full-length human cytomegalovirus protease has lower activity than recombinant processed protease domain in purified enzyme and cell-based assays.

Authors:  Arthur J Wittwer; Christy L Funckes-Shippy; Paul J Hippenmeyer
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

2.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

3.  Expression of two bovine rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal antibodies directed against the expressed proteins.

Authors:  C Aponte; N M Mattion; M K Estes; A Charpilienne; J Cohen
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Peptide substrate cleavage specificity of the human cytomegalovirus protease.

Authors:  V V Sardana; J A Wolfgang; C A Veloski; W J Long; K LeGrow; B Wolanski; E A Emini; R L LaFemina
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

5.  Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants.

Authors:  T R Jones; L Sun; G A Bebernitz; V P Muzithras; H J Kim; S H Johnston; E Z Baum
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Investigation of the specificity of the herpes simplex virus type 1 protease by point mutagenesis of the autoproteolysis sites.

Authors:  P J McCann; D R O'Boyle; I C Deckman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Autoprocessing of HSV-1 protease: effect of deletions on autoproteolysis.

Authors:  S Godefroy; C Guenet
Journal:  FEBS Lett       Date:  1995-01-03       Impact factor: 4.124

8.  The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus.

Authors:  Marlyse Buisson; Jean-François Hernandez; David Lascoux; Guy Schoehn; Eric Forest; Gérard Arlaud; Jean-Marie Seigneurin; Rob W H Ruigrok; Wim P Burmeister
Journal:  J Mol Biol       Date:  2002-11-15       Impact factor: 5.469

9.  Herpes simplex virus type 1 protease expressed in Escherichia coli exhibits autoprocessing and specific cleavage of the ICP35 assembly protein.

Authors:  I C Deckman; M Hagen; P J McCann
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.

Authors:  A R Welch; L M McNally; M R Hall; W Gibson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more
  1 in total

1.  Expression of immunogenic structural proteins of cyprinid herpesvirus 3 in vitro assessed using immunofluorescence.

Authors:  Sean J Monaghan; Kim D Thompson; James E Bron; Sven M Bergmann; Tae S Jung; Takashi Aoki; K Fiona Muir; Malte Dauber; Sven Reiche; Diana Chee; Shin M Chong; Jing Chen; Alexandra Adams
Journal:  Vet Res       Date:  2016-01-08       Impact factor: 3.683

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.